Prostate Cell News Volume 15.25 | Nov 1 2024

    0
    118







    2024-11-01 | PCN 15.25


    Prostate Cell News by STEMCELL Technologies
    Vol. 15.25 – 1 November, 2024
    TOP STORY

    Cell-Autonomous IL6ST Activation Suppresses Prostate Cancer Development via STAT3/ARF/p53-Driven Senescence and Confers an Immune-Active Tumor Microenvironment

    Scientists constitutively activated interleukin-6 cytokine family signal transducer (IL6ST) signaling in the prostate epithelium of a Pten-deficient prostate cancer mouse model in vivo and examined IL6ST expression in large cohorts of prostate cancer patients.
    [Molecular Cancer]

    Full Article
    An ISSCR 2022 COREdinates Webinar: Differentiation of High-Quality hPSCs Using STEMdiff â„¢ and TeSR â„¢-AOF, presented by Kim Snyder. Click to Watch Now.
    PUBLICATIONSListed by the impact factor of the journal

    Sialylated Glycoproteins Suppress Immune Cell Killing by Binding to Siglec-7 and Siglec-9 in Prostate Cancer

    The authors found that Siglec-7 and Siglec-9 were associated with poor prognosis in prostate cancer patients, and were highly expressed in myeloid cells, including macrophages, in prostate tumor tissues.
    [Journal of Clinical Investigation]

    AbstractGraphical Abstract

    IMPA1-Derived Inositol Maintains Stemness in Castration-Resistant Prostate Cancer via IMPDH2 Activation

    Scientists showed that IMPA1-derived inositol enriched in prostate cancer stem cells (PCSC) was a key metabolite crucially maintaining PCSCs for CRPC progression and androgen ablation therapy resistance.
    [Journal of Experimental Medicine]

    Abstract

    Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer

    Pathogenic or likely pathogenic germline variants in 26 DNA repair genes were assessed in relation to metastasis-free survival in high-risk, localized prostate cancer and to overall survival in metastatic castration-sensitive prostate cancer and metastatic CRPC.
    [Clinical Cancer Research]

    Abstract

    Zinc Ions Activate AKT and Promote Prostate Cancer Cell Proliferation via Disrupting AKT Intramolecular Interaction

    Investigators reported a regulatory mechanism of AKT kinase by zinc ions. Mechanistically, zinc ions directly bound to AKT and facilitated AKT activation through disrupting the interaction between PH and kinase domains within AKT molecule.
    [Oncogene]

    Abstract

    Disulfidptosis-Related Subtype and Prognostic Signature in Prostate Cancer

    Although SLC7A11 could increase the migration ability of tumor cells, BAY-876 effectively suppressed the viability of prostate cancer cells, particularly those with high SLC7A11 expression.
    [Biology Direct]

    Full Article

    Inflammation Impacts Androgen Receptor Signaling in Basal Prostate Stem Cells through Interleukin 1 Receptor Antagonist

    Using a unique transgenic mouse model that mimicked chronic non-bacterial prostatitis in men, researchers investigated the impact of inflammation on androgen receptor in basal prostate stem cells and their differentiation in vivo.
    [Communications Biology]

    Full Article

    Phase II Trial of PSMA PET CT Versus Planar Bone Scan and CT in Prostate Cancer Patients Progressing while on Androgen Deprivation Therapy

    This was a single-arm, head-to-head, prospective Phase II trial designed to enroll 102 men with prostate cancer who experienced biochemical progression during androgen deprivation therapy.
    [Scientific Reports]

    Full Article
    Meet the family of popular STEMCELL products. Click to explore.
    REVIEWS

    Interactions and Communications in the Prostate Tumor Microenvironment: Evolving Towards Effective Cancer Therapy

    Scientists discuss the various mechanisms by which the tumor microenvironment influences prostate cancer progression. The roles of different cells, cytokines, chemokines, and growth factors in modulating the immune response and prostate tumour growth are discussed.
    [Journal of Drug Targeting]

    AbstractGraphical Abstract

    Recent Advances in Basic Research on Prostate Cancer: Where We Are Heading?

    The authors provide an overview of recent basic research in prostate cancer, focusing on two main areas: prostate cells and their tumor microenvironments.
    [International Journal of Urology]

    Full Article
    INDUSTRY AND POLICY NEWS

    UCLA Efforts to Provide Prostate Cancer Treatment in the Community Gets $6 Million Boost

    The University of California, Los Angeles (UCLA) Urology department has been awarded $6 million from the California Department of Health Care Services to continue providing vital care and critical services to underinsured and uninsured Californians diagnosed with prostate cancer.
    [UCLA Health]

    Press Release

    Dr. Luca Valle Receives VA Grant to Improve Prediction of Radiorecurrent Prostate Cancer Outcomes

    Dr. Luca Valle at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), was awarded a $2.1 million grant from the US Department of Veterans Affairs (VA) to develop new methods to better understand biological factors that lead to prostate cancer coming back after radiation therapy.
    [UCLA Health]

    Press Release

    ESSA Pharma Announces Termination of Phase II Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

    ESSA Pharma, Inc. announced that it has made the decision to terminate the Phase II clinical trial evaluating masofaniten combined with enzalutamide versus enzalutamide single agent in patients with metastatic CRPC naïve to second-generation anti-androgens.
    [ESSA Pharma, Inc.]

    Press Release
    FEATURED EVENT

    2024 Singapore International Symposium

    December 11 – 13, 2024
    Singapore, Singapore

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellowship – Prostate Cancer

    Johns Hopkins Medicine – Baltimore, Maryland, United States

    PhD Candidate – AI To Identify Immune Targets

    Oslo University Hospital – Oslo, Norway

    Postdoctoral Research Associate – RNA Biology

    The University of British Columbia – Vancouver, British Columbia, Canada

    Associate Professor – Cancer Biology

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    Leader – Prostate Cancer Program

    Fred Hutch Cancer Center – Seattle, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2